Company Financials

WuXi Biologics Financials

Hong Kong dollar

business WuXi Biologics Company Profile

Main Stock Listing

HKEX: 2269

Market Capitalization HK$105.17 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE 30.35
Forward PE 25.05
Price to Sales TTM HK$5.62
Price to Book MRQ HK$2.53
Enterprise to Revenue 5.53
Enterprise to EBITDA 17.65

Financial Reports as of Dec. 31, 2024

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2024-12-31
Profit Margin 17.97%
Operating Margin 27.38%
Return on Assets TTM 5.05%
Return on Equity TTM 8.82%

Income Statement

Revenue TTM HK$20,451,397,669
Revenue per Share TTM HK$4.58
Quarterly Revenue Growth 18.30%
Gross Profit TTM HK$8,378,413,087
EBITDA HK$6,591,787,000
Net Income to Common TTM HK$3,675,244,189
Diluted EPS TTM HK$0.85
Quarterly Earnings Growth YoY 63.90%

Balance Sheet

Total Cash MRQ HK$11,728,291,817
Total Cash per Share MRQ HK$2.61
Total Debt MRQ HK$
Total Debt to Equity MRQ 10.86
Current Ratio MRQ 2.73
Book Value per Share MRQ HK$10.19

Cash Flow

Operating Cash Flow TTM HK$5,713,418,096
Levered Free Cash Flow TTM HK$-2,514,537,992

2269 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 4,105,937,505
Float Shares 3,578,119,239
Avg 10 Volume 37,992,663
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 13.07%
% Held by Institutions 35.41%

Stock Price Summary

Beta 0.55
Fifty Two Week Low HK$10.14
Fifty Two Week High HK$29.30
Fifty Two Week Change 58.78%
Day 50 MA HK$24.29
Day 200 MA HK$20.29

Dividends and Splits

Forward Annual Dividend Rate HK$
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate HK$0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date 2020-11-16